News Digging > Science > European committee: Regulators should deny Merck’s Lagevrio
European committee: Regulators should deny Merck’s Lagevrio
European committee: Regulators should deny Merck’s Lagevrio,A European medical committee recommends rejection of Merck’s COVID-19 treatment, Lagevrio, casting fresh doubt on a pill that also stirs concern among U.S. regulators. A European Medicines Agency committee says marketing authorization for the antiviral pill for use in the European Union should be refused.

European committee: Regulators should deny Merck’s Lagevrio

A European medical committee recommends rejection of Merck’s COVID-19 treatment, Lagevrio, casting fresh doubt on a pill that also stirs concern among U.S. regulators. A European Medicines Agency committee says marketing authorization for the antiviral pill for use in the European Union should be refused.